MML Investors Services
EDIT icon

MML Investors Services’s Editas Medicine EDIT Stock Holding History

MML Investors Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
52,088
+19,978
+62% +$58.4K ﹤0.01% 3144
2026
Q1 		$79.3K Sell
32,110
-5,745
-15% -$12.2K ﹤0.01% 2911
2025
Q4 		$77.6K Sell
37,855
-11,223
-23% -$32.4K ﹤0.01% 2951
2025
Q3 		$170K Buy
49,078
+4,830
+11% +$13.5K ﹤0.01% 2780
2025
Q2 		$97K Buy
44,248
+9,373
+27% +$15.3K ﹤0.01% 2750
2025
Q1 		$40K Buy
34,875
+18,106
+108% +$26.6K ﹤0.01% 2665
2024
Q4 		$21K Buy
16,769
+741
+5% +$1.89K ﹤0.01% 2650
2024
Q3 		$55K Buy
16,028
+3,639
+29% +$15.8K ﹤0.01% 2537
2024
Q2 		$58K Buy
12,389
+1,347
+12% +$7.6K ﹤0.01% 2438
2024
Q1 		$82K Sell
11,042
-1,174
-10% -$9.76K ﹤0.01% 2428
2023
Q4 		$124K Sell
12,216
-17,078
-58% -$150K ﹤0.01% 2368
2023
Q3 		$228K Buy
29,294
+1,672
+6% +$14.3K ﹤0.01% 2076
2023
Q2 		$227K Buy
27,622
+9,157
+50% +$79.8K ﹤0.01% 2097
2023
Q1 		$134K Buy
18,465
+1,079
+6% +$9.59K ﹤0.01% 1950
2022
Q4 		$154K Buy
17,386
+3,908
+29% +$42.9K ﹤0.01% 2056
2022
Q3 		$165K Buy
+13,478
New +$210K ﹤0.01% 1970
2021
Q3 		– Sell
-5,980
Closed -$339K – 1962
2021
Q2 		$339K Buy
+5,980
New +$221K ﹤0.01% 1535
2021
Q1 		– Sell
-4,124
Closed -$289K – 1804
2020
Q4 		$289K Buy
+4,124
New +$169K ﹤0.01% 1410

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MML Investors Services's EDIT Position: Q2 2026 in Review

MML Investors Services increased its Editas Medicine (EDIT) stake by 62% in Q2 2026, buying an estimated $58.4K and bringing the position to 52,088 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

MML Investors Services first reported a position in EDIT in Q4 2020 and has held it in 18 quarters since. The position peaked at $339K in Q2 2021. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • MML Investors Services held 52,088 shares of Editas Medicine worth $169K as of Q2 2026.
  • MML Investors Services bought 19,978 Editas Medicine shares in Q2 2026, an estimated $58.4K.
  • Editas Medicine made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #3144 holding.
  • MML Investors Services first reported a position in Editas Medicine in Q4 2020 and has held it in 18 quarters since.
  • MML Investors Services's Editas Medicine position peaked at $339K in Q2 2021.
  • 215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.